COLPAL Colgate Palmolive (India) Q1 FY27 results (Apr–Jun 2026) and concall
Colgate Palmolive (India) Limited delivered a strong Q1 FY27, marked by double-digit growth in sales and profitability, driven by a strategic focus on premiumization and increased advertising investments. The company maintained robust gross margins through operational efficiencies and is actively working to grow the oral care category and revitalize its personal care segment through a new partnership. Management expressed confidence in its balanced growth model while closely monitoring macro-economic factors.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 11.8%, net profit up 6.9% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,462 | 1,463 | 1,434 | 1,520 | 1,486 +2% | 1,595 +9% | 1,603 +12% |
| EBITDA | 454 | 498 | 453 | 465 | 442 −3% | 510 +2% | 483 +7% |
| Net profit | 323 | 355 | 321 | 328 | 324 +0% | 353 −1% | 343 +7% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
